Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Atea Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +3 vs. Q1 2025
- Shares held
- 52.7M
- −255.5K (−0.5%) vs. Q1 2025
- Total value
- $189.7M
- +$31.4M (+19.8%) vs. Q1 2025
- New holders
- 13
- 36 more added
- Sold out
- 10
- 27 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| IFP Advisors, Inc | 0 | $606 | 0.00% | 0 | Unchanged |
| Farther Finance Advisors, LLC | 149 | $536 | 0.00% | +3+2.1% | Added |
| Nisa Investment Advisors, LLC | 106 | $382 | 0.00% | −175−62.3% | Reduced |
| MAI Capital Management | 95 | $342 | 0.00% | 00.0% | Unchanged |
| Rothschild Investment LLC | 85 | $306 | 0.00% | +85 | New |
| SBI Securities Co., Ltd. | 2 | $7 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 85 | $0 | 0.00% | +3+3.7% | Added |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −75,088−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −37,802−100.0% | Sold out |
| Aldebaran Capital, LLC | 0 | $0 | 0.00% | −37,500−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −32,520−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −30,087−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −21,992−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −17,122−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −15,756−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −5,591−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −3,188−100.0% | Sold out |